Therapeutics News and Research

RSS
Free licences of European patents on the hereditary breast cancer gene BRCA2

Free licences of European patents on the hereditary breast cancer gene BRCA2

Bionomics BNO69 angiogenesis gene discovery published

Bionomics BNO69 angiogenesis gene discovery published

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Recommendation against the use of chemotherapy sensitivity and resistance assays

Recommendation against the use of chemotherapy sensitivity and resistance assays

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

Identification of PIK3CA as an oncogene associated with brain cancers opens the door to new screening processes

New process that simplifies the production of proteins

New process that simplifies the production of proteins

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

New DNA microarray to speed bone disease research

New DNA microarray to speed bone disease research

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

3M and MicroDose Technologies Inc. team up to bring advanced electronic dry powder inhaler to market

3M and MicroDose Technologies Inc. team up to bring advanced electronic dry powder inhaler to market

Market research 'World RNAi Markets: Current and Future Outlook'

Market research 'World RNAi Markets: Current and Future Outlook'

Targeted therapeutics capable of preventing or limiting the metastasis of skin cancer

Targeted therapeutics capable of preventing or limiting the metastasis of skin cancer

Strategic analysis of the breast cancer therapeutics pipeline

Strategic analysis of the breast cancer therapeutics pipeline

Cell Therapeutics receives Fast Track Designation for Pixantrone, treatment for aggressive non-Hodgkin's lymphoma

Cell Therapeutics receives Fast Track Designation for Pixantrone, treatment for aggressive non-Hodgkin's lymphoma

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Natural products to be developed as anti-cancer therapeutics

Natural products to be developed as anti-cancer therapeutics

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax